-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, M9tod3abuEYQiJAy6NCJAJpg8pH+mabTL7Bp9osK48+/1qhADzNdsZdk9IbRDIxc LOteXeesmG4XYQUA1NR4jg== 0000950116-06-001663.txt : 20060524 0000950116-06-001663.hdr.sgml : 20060524 20060524091003 ACCESSION NUMBER: 0000950116-06-001663 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20060523 ITEM INFORMATION: Bankruptcy or Receivership ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20060524 DATE AS OF CHANGE: 20060524 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aphton CORP CENTRAL INDEX KEY: 0000840319 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 953640931 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-19122 FILM NUMBER: 06862950 BUSINESS ADDRESS: STREET 1: 1628 JFK BOULEVARD STREET 2: SUITE 501 CITY: PHILADELPHIA STATE: PA ZIP: 19103 BUSINESS PHONE: 2152184340 MAIL ADDRESS: STREET 1: 1628 JFK BOULEVARD STREET 2: SUITE 501 CITY: PHILADELPHIA STATE: PA ZIP: 19103 FORMER COMPANY: FORMER CONFORMED NAME: APHTON CORP DATE OF NAME CHANGE: 19930328 8-K 1 eight-k.htm 8-K Prepared and filed by St Ives Financial

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549

__________________

FORM 8-K

__________________

CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported) May 23, 2006

__________________

Aphton Corporation
(Exact Name of Registrant as Specified in Its Charter)

__________________

Delaware
(State or Other Jurisdiction of Incorporation)

               
000-19122
(Commission File Number)
        
95-3640931
(IRS Employer Identification No.)
  
         
         
8 Penn Center, 1628 JFK Boulevard, Philadelphia, PA
(Address of Principal Executive Offices)
        
19103
(Zip Code)
  
         

(215) 218-4340
(Registrant’s Telephone Number, Including Area Code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Back to Contents

Item 1.03.       Bankruptcy or Receivership

     On May 23, 2006, Aphton Corporation filed a voluntary petition under chapter 11, title 11 of the United States Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware. The Company is seeking offers to purchase its assets out of bankruptcy. Any sale will be subject to Bankruptcy Court approval.  

Item 9.01 Financial Statements and Exhibits.

(c) Exhibits

               
Number         Description  
               
99.1          Press release dated May 24, 2006.  

Back to Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

         
APHTON CORPORATION
     
Date:  May 24, 2006 By: /s/ James F. Smith               
Name: James F. Smith
Title: Senior Vice President and Chief Financial Officer

Back to Contents

EXHIBIT INDEX

               
Number
 		         Description
 		  
         
99.1           Press release dated May 24, 2006.  

GRAPHIC 2 emptybox.gif GRAPHIC begin 644 emptybox.gif M1TE&.#EA#``,`/?^``````$!`0("`@,#`P0$!`4%!08&!@<'!P@("`D)"0H* M"@L+"PP,#`T-#0X.#@\/#Q`0$!$1$1(2$A,3$Q04%!45%186%A<7%Q@8&!D9 M&1H:&AL;&QP<'!T='1X>'A\?'R`@("$A(2(B(B,C(R0D)"4E)28F)B7IZ>GM[>WQ\?'U]?7Y^?G]_?X"`@(&!@8*" M@H.#@X2$A(6%A8:&AH>'AXB(B(F)B8J*BHN+BXR,C(V-C8Z.CH^/CY"0D)&1 MD9*2DI.3DY24E)65E9:6EI>7EYB8F)F9F9J:FIN;FYRGI^?GZ"@ MH*&AH:*BHJ.CHZ2DI*6EI::FIJ>GIZBHJ*FIJ:JJJJNKJZRLK*VMK:ZNKJ^O MK["PL+&QL;*RLK.SL[2TM+6UM;:VMK>WM[BXN+FYN;JZNKN[N[R\O+V]O;Z^ MOK^_O\#`P,'!P<+"PL/#P\3$Q,7%Q<;&QL?'Q\C(R,G)RWM_?W^#@X.'AX>+BXN/CX^3DY.7EY>;FYN?GY^CHZ.GIZ>KJZNOK MZ^SL[.WM[>[N[N_O[_#P\/'Q\?+R\O/S\_3T]/7U]?;V]O?W]_CX^/GY^?KZ M^OO[^_S\_/W]_?[^_O___R'Y!`$``/X`+``````,``P`!P@Z`/\)'$APX)L? M"!,J_/<#F;B'$!\:8"BNX,`#%"T*Q/BCHD:.'BV"U/AOY,>,)SN2Y&C@@,N7 &+@$$!``[ ` end EX-99 3 ex99-1.htm EXHIBIT 99.1 Prepared and filed by St Ives Financial

Back to Contents

Contacts:

Aphton Investor Relations

(215) 218-4371

ir@aphton.com

Aphton Corporation Files For Bankruptcy

PHILADELPHIA, PA – May 23, 2006 – Aphton Corporation (NASDAQ: APHT) announced today that it has filed a voluntary petition under chapter 11, title 11 of the United States Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware. The Company is seeking offers to purchase its assets out of bankruptcy. Any sale will be subject to Bankruptcy Court approval.  

“We regret that circumstances have forced the company to file for chapter 11 bankruptcy protection. However, we appreciate the support we have received over the years from our employees, vendors, investors and collaborative partners,” stated Patrick Mooney, MD, Chairman and Chief Executive Officer of Aphton.

About Aphton

Aphton Corporation, headquartered in Philadelphia, Pennsylvania, is a biopharmaceutical company.

SOURCE: APHTON CORPORATION

-----END PRIVACY-ENHANCED MESSAGE-----